Gene: ZDHHC14
Official Full Name: zDHHC palmitoyltransferase 14provided by HGNC
Gene Summary: Enables palmitoyltransferase activity. Involved in peptidyl-L-cysteine S-palmitoylation. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12422 | ZDHHC14 Knockout cell line (HeLa) | Human | ZDHHC14 | 1:3~1:6 | Negative | Online Inquiry |
KO12423 | ZDHHC14 Knockout cell line (HCT 116) | Human | ZDHHC14 | 1:2~1:4 | Negative | Online Inquiry |
KO12424 | ZDHHC14 Knockout cell line (HEK293) | Human | ZDHHC14 | 1:3~1:6 | Negative | Online Inquiry |
KO12425 | ZDHHC14 Knockout cell line (A549) | Human | ZDHHC14 | 1:3~1:4 | Negative | Online Inquiry |
ZDHHC14 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to incorporate a deletion or inactivation of the ZDHHC14 gene, which encodes a member of the zinc finger DHHC-type palmitoyltransferase family. This gene plays a pivotal role in post-translational modifications, particularly in the palmitoylation of proteins, a biochemical process critical for regulating protein localization, stability, and function within cellular membranes.
The primary function of the ZDHHC14 Gene Knockout Cell Lines lies in their capacity to facilitate the study of palmitoylation's impact on cellular signaling and membrane dynamics. By removing the ZDHHC14 gene, researchers gain a powerful tool to investigate the downstream effects on various cellular pathways, enabling a deeper understanding of the gene's role in conditions such as cancer, neurodegenerative diseases, and metabolic disorders. These knockout cell lines offer insights into alterations in protein function and interactions, providing a clearer picture of the pathophysiological mechanisms involved.
In research settings, these cell lines serve as valuable models to test hypotheses related to protein interactions and signaling pathways influenced by palmitoylation. Their utility extends to drug discovery and development, where understanding the effects of therapeutics on these pathways can lead to more targeted and effective interventions.
Compared to traditional cell lines, the ZDHHC14 knockout models provide specificity and precision, allowing researchers to isolate the effects of palmitoylation without the confounding variables present in wild-type cells. This specificity enhances the reproducibility and reliability of experimental outcomes, offering a competitive edge in research applications.
Our ZDHHC14 Gene Knockout Cell Lines reflect our commitment to providing high-quality, robust research tools. With a team of experts focused on advancing genetic engineering technologies, we ensure that our products meet the needs of researchers and clinicians, empowering them to drive innovation and discovery in the rapidly evolving field of biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.